WB results validated the expression of EVs specific markers and cancer specific marker, we obtained distinct bands for CD9, TSG101 and PDL-1 verifying the presence of the EVs specific markers and cancer specific marker, respectively, while calnexin as an EVs’ negative marker (Figure 2B). Here, CD9 is linked to cancer.